Advanced PDE5 Research Compound
Retho-Cialis USA Beligas is a phosphodiesterase type 5 (PDE5) inhibitor research chemical produced by Beligas Pharmaceuticals for laboratory investigation. This tadalafil citrate compound enables researchers to examine selective enzyme inhibition mechanisms and vascular signalling pathways in controlled experimental settings. When conducting metabolic research at Stroid UK Shop, scientists can investigate how PDE5 modulation affects cellular cyclic nucleotide concentrations and downstream signalling cascades.
Laboratory Investigation Applications
Research teams utilise this compound to examine PDE5-mediated pathways in cardiovascular and smooth muscle tissue models. Scientists can investigate the selective inhibition profile compared to other phosphodiesterase isoforms, studying tissue-specific responses in endothelial cell cultures. The compound’s extended half-life characteristics make it valuable for examining sustained enzyme modulation effects in time-course studies. Researchers exploring cialis research compounds often evaluate dose-response relationships and receptor binding kinetics in isolated tissue preparations.
Comparative studies with other PDE inhibitors help elucidate selectivity profiles and mechanism differences. Cell biology research teams examine how PDE5 inhibition affects nitric oxide-cGMP signalling in various tissue types. The compound enables investigation of vascular smooth muscle relaxation mechanisms and endothelial function modulation. Researchers studying metabolic pathways can also investigate selective androgen receptor modulators and bioactive peptides for comprehensive experimental designs.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Tadalafil Citrate |
| Manufacturer | Beligas Pharmaceuticals |
| Product Code | EU10607 |
| Target Enzyme | Phosphodiesterase Type 5 |
| Molecular Formula | Verify with supplier |
| CAS Number | Verify with supplier |
| Storage Conditions | Room temperature, dry environment |
| Research Applications | PDE5 inhibition studies, vascular research |
Research-Only Compliance
Retho-Cialis USA Beligas is manufactured exclusively for laboratory research applications and in-vitro experimental studies. This compound is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must handle according to institutional safety protocols and maintain proper documentation for experimental use. All studies should comply with relevant laboratory guidelines and institutional review board requirements for research chemical investigation.
